{"entity":{"type":"insider","cik":"0001658080","url":"/insider/0001658080","json_url":"/insider/0001658080.json","name":"Francois Cedric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":64,"n_filings":39,"first":"2019-08-16","last":"2026-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Francois Cedric","source":"filing","n_filings":39,"first_seen":"2019-08-16","last_seen":"2026-01-23"}],"transactions":[{"id":6038545,"accession":"0001492422-26-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000057","line_url":"/filing/0001492422-26-000057#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27192.0,"shares_display":"27,192","price_per_share":21.7654,"price_display":"21.77","price_state":"stated","total_value":591844.7568,"total_display":"591,844.76","total_whole":"591,845","shares_owned_after":286045.0,"shares_owned_after_display":"286,045","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":6054220,"accession":"0001492422-26-000041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000041","line_url":"/filing/0001492422-26-000041#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8182.0,"shares_display":"8,182","price_per_share":19.7929,"price_display":"19.79","price_state":"stated","total_value":161945.5078,"total_display":"161,945.51","total_whole":"161,946","shares_owned_after":313237.0,"shares_owned_after_display":"313,237","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-21","scope":"insider"},{"id":5783996,"accession":"0001492422-26-000028","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000028","line_url":"/filing/0001492422-26-000028#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10186.0,"shares_display":"10,186","price_per_share":22.1872,"price_display":"22.19","price_state":"stated","total_value":225998.8192,"total_display":"225,998.82","total_whole":"225,999","shares_owned_after":321419.0,"shares_owned_after_display":"321,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider"},{"id":4343393,"accession":"0001193125-25-192797","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-192797","line_url":"/filing/0001193125-25-192797#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49963.0,"shares_display":"49,963","price_per_share":28.39,"price_display":"28.39","price_state":"stated","total_value":1418449.57,"total_display":"1,418,449.57","total_whole":"1,418,450","shares_owned_after":307946.0,"shares_owned_after_display":"307,946","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-28","filed_date":"2025-08-29","scope":"insider"},{"id":4343390,"accession":"0001193125-25-192797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-192797","line_url":"/filing/0001193125-25-192797#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":175037.0,"shares_display":"175,037","price_per_share":28.19,"price_display":"28.19","price_state":"stated","total_value":4934293.03,"total_display":"4,934,293.03","total_whole":"4,934,293","shares_owned_after":357909.0,"shares_owned_after_display":"357,909","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-27","filed_date":"2025-08-29","scope":"insider"},{"id":5106454,"accession":"0001127602-25-019413","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-019413","line_url":"/filing/0001127602-25-019413#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19725.0,"shares_display":"19,725","price_per_share":20.2147,"price_display":"20.21","price_state":"stated","total_value":398734.9575,"total_display":"398,734.96","total_whole":"398,735","shares_owned_after":331605.0,"shares_owned_after_display":"331,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-17","filed_date":"2025-07-18","scope":"insider"},{"id":5106429,"accession":"0001127602-25-019265","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-25-019265","line_url":"/filing/0001127602-25-019265#line-4","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":20.0884,"price_display":"20.09","price_state":"stated","total_value":38167.96,"total_display":"38,167.96","total_whole":"38,168","shares_owned_after":342333.0,"shares_owned_after_display":"342,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-15","filed_date":"2025-07-16","scope":"insider"},{"id":5106422,"accession":"0001127602-25-019265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-25-019265","line_url":"/filing/0001127602-25-019265#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":137465.0,"shares_display":"137,465","price_per_share":20.1864,"price_display":"20.19","price_state":"stated","total_value":2774923.476,"total_display":"2,774,923.48","total_whole":"2,774,923","shares_owned_after":343433.0,"shares_owned_after_display":"343,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-14","filed_date":"2025-07-16","scope":"insider"},{"id":4550795,"accession":"0001127602-25-002375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-002375","line_url":"/filing/0001127602-25-002375#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2824.0,"shares_display":"2,824","price_per_share":29.5236,"price_display":"29.52","price_state":"stated","total_value":83374.6464,"total_display":"83,374.65","total_whole":"83,375","shares_owned_after":415695.0,"shares_owned_after_display":"415,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-01-30","scope":"insider"},{"id":4328312,"accession":"0001127602-25-001837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001837","line_url":"/filing/0001127602-25-001837#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13551.0,"shares_display":"13,551","price_per_share":30.4255,"price_display":"30.43","price_state":"stated","total_value":412295.9505,"total_display":"412,295.95","total_whole":"412,296","shares_owned_after":418519.0,"shares_owned_after_display":"418,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":4168912,"accession":"0001127602-25-001620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001620","line_url":"/filing/0001127602-25-001620#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6007.0,"shares_display":"6,007","price_per_share":29.9582,"price_display":"29.96","price_state":"stated","total_value":179958.9074,"total_display":"179,958.91","total_whole":"179,959","shares_owned_after":301408.0,"shares_owned_after_display":"301,408","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-21","scope":"insider"},{"id":5163829,"accession":"0001127602-25-001197","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001197","line_url":"/filing/0001127602-25-001197#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6247.0,"shares_display":"6,247","price_per_share":28.7021,"price_display":"28.70","price_state":"stated","total_value":179302.0187,"total_display":"179,302.02","total_whole":"179,302","shares_owned_after":307415.0,"shares_owned_after_display":"307,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-14","scope":"insider"},{"id":2035829,"accession":"0001127602-24-008505","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001127602-24-008505","line_url":"/filing/0001127602-24-008505","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":64.1148232556,"price_display":"64.11","price_state":"stated","total_value":16028705.8139,"total_display":"16,028,705.81","total_whole":"16,028,706","shares_owned_after":314075.0,"shares_owned_after_display":"314,075","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider","n_lines":5},{"id":2373815,"accession":"0001127602-24-004718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-004718","line_url":"/filing/0001127602-24-004718#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3962.0,"shares_display":"3,962","price_per_share":67.7669,"price_display":"67.77","price_state":"stated","total_value":268492.4578,"total_display":"268,492.46","total_whole":"268,492","shares_owned_after":313662.0,"shares_owned_after_display":"313,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":2580632,"accession":"0001127602-24-002740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-002740","line_url":"/filing/0001127602-24-002740#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2843.0,"shares_display":"2,843","price_per_share":64.1382,"price_display":"64.14","price_state":"stated","total_value":182344.9026,"total_display":"182,344.90","total_whole":"182,345","shares_owned_after":317624.0,"shares_owned_after_display":"317,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":2306731,"accession":"0001127602-24-001970","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-001970","line_url":"/filing/0001127602-24-001970#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13431.0,"shares_display":"13,431","price_per_share":64.996,"price_display":"65.00","price_state":"stated","total_value":872961.276,"total_display":"872,961.28","total_whole":"872,961","shares_owned_after":320467.0,"shares_owned_after_display":"320,467","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-23","scope":"insider"},{"id":3201384,"accession":"0001127602-24-001431","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-001431","line_url":"/filing/0001127602-24-001431#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7851.0,"shares_display":"7,851","price_per_share":66.8086,"price_display":"66.81","price_state":"stated","total_value":524514.3186,"total_display":"524,514.32","total_whole":"524,514","shares_owned_after":333898.0,"shares_owned_after_display":"333,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-17","scope":"insider"},{"id":8671068,"accession":"0000950170-23-065613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-065613","line_url":"/filing/0000950170-23-065613#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":48.8,"price_display":"48.80","price_state":"stated","total_value":244000.0,"total_display":"244,000.00","total_whole":"244,000","shares_owned_after":269655.0,"shares_owned_after_display":"269,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-21","scope":"insider"},{"id":8432763,"accession":"0001127602-23-023560","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-23-023560","line_url":"/filing/0001127602-23-023560","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":41.753063,"price_display":"41.75","price_state":"stated","total_value":6262959.45,"total_display":"6,262,959.45","total_whole":"6,262,959","shares_owned_after":434939.0,"shares_owned_after_display":"434,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-01","scope":"insider","n_lines":2},{"id":8292543,"accession":"0001127602-23-016189","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001127602-23-016189","line_url":"/filing/0001127602-23-016189","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":85.66333760333333,"price_display":"85.66","price_state":"stated","total_value":2569900.1281,"total_display":"2,569,900.13","total_whole":"2,569,900","shares_owned_after":287310.0,"shares_owned_after_display":"287,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider","n_lines":6},{"id":8258183,"accession":"0001127602-23-013309","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-013309","line_url":"/filing/0001127602-23-013309#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":82.024,"price_display":"82.02","price_state":"stated","total_value":2460720.0,"total_display":"2,460,720.00","total_whole":"2,460,720","shares_owned_after":637601.0,"shares_owned_after_display":"637,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-18","filed_date":"2023-04-20","scope":"insider"},{"id":8587246,"accession":"0001127602-23-011206","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-011206","line_url":"/filing/0001127602-23-011206#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":62.7444,"price_display":"62.74","price_state":"stated","total_value":1882332.0,"total_display":"1,882,332.00","total_whole":"1,882,332","shares_owned_after":1144591.0,"shares_owned_after_display":"1,144,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-03-23","scope":"insider"},{"id":6478928,"accession":"0001127602-22-028072","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-22-028072","line_url":"/filing/0001127602-22-028072","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28200.0,"shares_display":"28,200","price_per_share":52.05614585460993,"price_display":"52.06","price_state":"stated","total_value":1467983.3131,"total_display":"1,467,983.31","total_whole":"1,467,983","shares_owned_after":965128.0,"shares_owned_after_display":"965,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-21","scope":"insider","n_lines":2},{"id":3291266,"accession":"0001127602-20-031562","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-031562","line_url":"/filing/0001127602-20-031562#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":52.16,"price_display":"52.16","price_state":"stated","total_value":260800.0,"total_display":"260,800.00","total_whole":"260,800","shares_owned_after":1113079.0,"shares_owned_after_display":"1,113,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-16","scope":"insider"},{"id":3229482,"accession":"0001127602-20-029369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-029369","line_url":"/filing/0001127602-20-029369#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":39.38,"price_display":"39.38","price_state":"stated","total_value":196900.0,"total_display":"196,900.00","total_whole":"196,900","shares_owned_after":1078079.0,"shares_owned_after_display":"1,078,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-17","scope":"insider"},{"id":3248475,"accession":"0001127602-20-027098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-027098","line_url":"/filing/0001127602-20-027098#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":34.46,"price_display":"34.46","price_state":"stated","total_value":172300.0,"total_display":"172,300.00","total_whole":"172,300","shares_owned_after":1083079.0,"shares_owned_after_display":"1,083,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-15","filed_date":"2020-10-16","scope":"insider"},{"id":2428760,"accession":"0001127602-20-025183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-025183","line_url":"/filing/0001127602-20-025183#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.96,"price_display":"30.96","price_state":"stated","total_value":154800.0,"total_display":"154,800.00","total_whole":"154,800","shares_owned_after":1088079.0,"shares_owned_after_display":"1,088,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-15","filed_date":"2020-09-16","scope":"insider"},{"id":2813827,"accession":"0001127602-20-024043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-024043","line_url":"/filing/0001127602-20-024043#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3457.0,"shares_display":"3,457","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":103710.0,"total_display":"103,710.00","total_whole":"103,710","shares_owned_after":1093079.0,"shares_owned_after_display":"1,093,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-20","filed_date":"2020-08-21","scope":"insider"},{"id":2062344,"accession":"0001127602-20-023992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-023992","line_url":"/filing/0001127602-20-023992#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1543.0,"shares_display":"1,543","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":46290.0,"total_display":"46,290.00","total_whole":"46,290","shares_owned_after":1096536.0,"shares_owned_after_display":"1,096,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":2108298,"accession":"0001127602-20-021646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-021646","line_url":"/filing/0001127602-20-021646#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":32.12,"price_display":"32.12","price_state":"stated","total_value":160600.0,"total_display":"160,600.00","total_whole":"160,600","shares_owned_after":1098079.0,"shares_owned_after_display":"1,098,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-15","filed_date":"2020-07-16","scope":"insider"},{"id":3215292,"accession":"0001127602-20-019731","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-019731","line_url":"/filing/0001127602-20-019731#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.21,"price_display":"30.21","price_state":"stated","total_value":151050.0,"total_display":"151,050.00","total_whole":"151,050","shares_owned_after":1103079.0,"shares_owned_after_display":"1,103,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-16","scope":"insider"},{"id":2566195,"accession":"0001127602-20-017181","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-017181","line_url":"/filing/0001127602-20-017181#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":29.92,"price_display":"29.92","price_state":"stated","total_value":149600.0,"total_display":"149,600.00","total_whole":"149,600","shares_owned_after":1108079.0,"shares_owned_after_display":"1,108,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-19","scope":"insider"},{"id":3246501,"accession":"0001127602-20-014100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-20-014100","line_url":"/filing/0001127602-20-014100#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":29.77,"price_display":"29.77","price_state":"stated","total_value":148850.0,"total_display":"148,850.00","total_whole":"148,850","shares_owned_after":1113079.0,"shares_owned_after_display":"1,113,079","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-15","filed_date":"2020-04-17","scope":"insider"},{"id":2641948,"accession":"0001127602-20-011263","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001127602-20-011263","line_url":"/filing/0001127602-20-011263#line-8","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15065.0,"shares_display":"15,065","price_per_share":21.579,"price_display":"21.58","price_state":"stated","total_value":325087.635,"total_display":"325,087.64","total_whole":"325,088","shares_owned_after":1056579.0,"shares_owned_after_display":"1,056,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"},{"id":2641945,"accession":"0001127602-20-011263","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001127602-20-011263","line_url":"/filing/0001127602-20-011263#line-7","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12060.0,"shares_display":"12,060","price_per_share":20.693,"price_display":"20.69","price_state":"stated","total_value":249557.58,"total_display":"249,557.58","total_whole":"249,558","shares_owned_after":1071644.0,"shares_owned_after_display":"1,071,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"},{"id":2641941,"accession":"0001127602-20-011263","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001127602-20-011263","line_url":"/filing/0001127602-20-011263#line-6","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3212.0,"shares_display":"3,212","price_per_share":22.278,"price_display":"22.28","price_state":"stated","total_value":71556.936,"total_display":"71,556.94","total_whole":"71,557","shares_owned_after":1053367.0,"shares_owned_after_display":"1,053,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"},{"id":2641939,"accession":"0001127602-20-011263","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-20-011263","line_url":"/filing/0001127602-20-011263#line-5","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2192.0,"shares_display":"2,192","price_per_share":21.569,"price_display":"21.57","price_state":"stated","total_value":47279.248,"total_display":"47,279.25","total_whole":"47,279","shares_owned_after":1084404.0,"shares_owned_after_display":"1,084,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"},{"id":2641935,"accession":"0001127602-20-011263","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-20-011263","line_url":"/filing/0001127602-20-011263#line-4","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2108.0,"shares_display":"2,108","price_per_share":20.728,"price_display":"20.73","price_state":"stated","total_value":43694.624,"total_display":"43,694.62","total_whole":"43,695","shares_owned_after":1086596.0,"shares_owned_after_display":"1,086,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"},{"id":2641932,"accession":"0001127602-20-011263","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-20-011263","line_url":"/filing/0001127602-20-011263#line-3","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001658080","owner_name":"Francois Cedric","owner_display_name":"Francois Cedric","owner_url":"/insider/0001658080","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":22.286,"price_display":"22.29","price_state":"stated","total_value":15600.2,"total_display":"15,600.20","total_whole":"15,600","shares_owned_after":1083704.0,"shares_owned_after_display":"1,083,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"}],"collapsed":true,"next_cursor":"2020-03-16|2641932","ledger_fault":false,"count":{"value":64,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":64,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":64},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Director, Officer (Chief Executive Officer)","n_filings":39,"first_seen":"2019-08-16","last_seen":"2026-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001658080","retrieved_at":"2026-08-25T20:19:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}